Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Non Operating Income (2020 - 2025)

Immucell's Non Operating Income history spans 9 years, with the latest figure at -$110118.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 9.24% year-over-year to -$110118.0; the TTM value through Dec 2025 reached -$459191.0, up 11.0%, while the annual FY2024 figure was -$506414.0, 2213.13% down from the prior year.
  • Non Operating Income reached -$110118.0 in Q4 2025 per ICCC's latest filing, up from -$155367.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $244275.0 in Q3 2023 to a low of -$155367.0 in Q3 2025.
  • Average Non Operating Income over 5 years is -$75536.4, with a median of -$74044.5 recorded in 2021.
  • The largest YoY upside for Non Operating Income was 809.67% in 2023 against a maximum downside of 314.04% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$70156.0 in 2021, then surged by 53.53% to -$32602.0 in 2022, then plummeted by 314.04% to -$134985.0 in 2023, then grew by 25.32% to -$100804.0 in 2024, then decreased by 9.24% to -$110118.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Non Operating Income are -$110118.0 (Q4 2025), -$155367.0 (Q3 2025), and -$65778.0 (Q2 2025).